Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 72

1.

A systematic review of economic evaluation studies of tuberculosis control in high-income countries.

Verdier JE, de Vlas SJ, Baltussen R, Richardus JH.

Int J Tuberc Lung Dis. 2011 Dec;15(12):1587-98. doi: 10.5588/ijtld.10.0332. Epub 2011 Jul 6. Review.

PMID:
21740647
2.

Women and tuberculosis.

Connolly M, Nunn P.

World Health Stat Q. 1996;49(2):115-9. Review.

PMID:
9050189
3.
4.

[Development of antituberculous drugs: current status and future prospects].

Tomioka H, Namba K.

Kekkaku. 2006 Dec;81(12):753-74. Review. Japanese.

PMID:
17240921
5.

Tuberculosis and HIV-infection in developing countries.

Broekmans JF.

Trop Geogr Med. 1991 Jul;43(3):S13-21.

PMID:
1687768
6.

Economic evaluation of public-private mix for tuberculosis care and control, India. Part II. Cost and cost-effectiveness.

Pantoja A, Lönnroth K, Lal SS, Chauhan LS, Uplekar M, Padma MR, Unnikrishnan KP, Rajesh J, Kumar P, Sahu S, Wares F, Floyd K.

Int J Tuberc Lung Dis. 2009 Jun;13(6):705-12.

PMID:
19460245
7.

The cost of intensified case finding and isoniazid preventive therapy for HIV-infected patients in Battambang, Cambodia.

Sutton BS, Arias MS, Chheng P, Eang MT, Kimerling ME.

Int J Tuberc Lung Dis. 2009 Jun;13(6):713-8.

PMID:
19460246
8.

Cost-effectiveness of treating multidrug-resistant tuberculosis.

Resch SC, Salomon JA, Murray M, Weinstein MC.

PLoS Med. 2006 Jul;3(7):e241.

9.

Economic evaluation of public-private mix for tuberculosis care and control, India. Part I. Socio-economic profile and costs among tuberculosis patients.

Pantoja A, Floyd K, Unnikrishnan KP, Jitendra R, Padma MR, Lal SS, Uplekar M, Chauhan LS, Kumar P, Sahu S, Wares F, Lönnroth K.

Int J Tuberc Lung Dis. 2009 Jun;13(6):698-704.

PMID:
19460244
10.

Socio-economic dimensions of tuberculosis control: review of studies over two decades from Tuberculosis Research Center.

Muniyandi M, Ramachandran R, Balasubramanian R, Narayanan PR.

J Commun Dis. 2006 Mar;38(3):204-15.

PMID:
17373353
11.

Therapeutic review: tuberculosis.

Houston S, Pozniak A, Ray CS.

Cent Afr J Med. 1991 Aug;37(8):250-9. Review.

PMID:
1807799
12.

Comparison of two cash transfer strategies to prevent catastrophic costs for poor tuberculosis-affected households in low- and middle-income countries: An economic modelling study.

Rudgard WE, Evans CA, Sweeney S, Wingfield T, Lönnroth K, Barreira D, Boccia D.

PLoS Med. 2017 Nov 7;14(11):e1002418. doi: 10.1371/journal.pmed.1002418. eCollection 2017 Nov.

13.

Chemoprophylaxis for tuberculosis in HIV-infected individuals in sub-Saharan Africa.

Nuwaha F.

East Afr Med J. 1998 Sep;75(9):520-7. Review.

PMID:
10493054
14.

Drug-resistant tuberculosis in the European Union: opportunities and challenges for control.

Fears R, Kaufmann S, Ter Meulen V, Zumla A; EASAC Working Group.

Tuberculosis (Edinb). 2010 May;90(3):182-7. doi: 10.1016/j.tube.2010.03.008. Epub 2010 Apr 10. Review.

PMID:
20382566
15.

Cost for tuberculosis care in developed countries: which data for an economic evaluation?

Trieste L, Turchetti G.

J Rheumatol Suppl. 2014 May;91:83-5. doi: 10.3899/jrheum.140107. Review.

PMID:
24789005
16.
17.

[Reform of Japan's NTP and its technical perspectives].

Mori T.

Kekkaku. 2004 Oct;79(10):587-604. Review. Japanese.

PMID:
15631111
18.

Cost-comparison of different management policies for tuberculosis patients in Italy. AIPO TB Study Group.

Migliori GB, Ambrosetti M, Besozzi G, Farris B, Nutini S, Saini L, Casali L, Nardini S, Bugiani M, Neri M, Raviglione MC.

Bull World Health Organ. 1999;77(6):467-76.

19.

How affordable are tuberculosis diagnosis and treatment in rural China? An analysis from community and tuberculosis patient perspectives.

Liu X, Thomson R, Gong Y, Zhao F, Squire SB, Tolhurst R, Zhao X, Yan F, Tang S.

Trop Med Int Health. 2007 Dec;12(12):1464-71.

20.

Supplemental Content

Support Center